These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6097122)

  • 1. Cefmenoxime efficacy, safety, and pharmacokinetics in critical care patients with nosocomial pneumonia.
    Schentag JJ; Reitberg DP; Cumbo TJ
    Am J Med; 1984 Dec; 77(6A):34-42. PubMed ID: 6097122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefmenoxime in the treatment of nosocomial pneumonias in critical care patients.
    Reitberg DP; Cumbo TJ; Schentag JJ
    J Antimicrob Chemother; 1984 Jul; 14(1):81-91. PubMed ID: 6090380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
    Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
    Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for dual individualization with cefmenoxime.
    Schentag JJ; Smith IL; Swanson DJ; DeAngelis C; Fracasso JE; Vari A; Vance JW
    Am J Med; 1984 Dec; 77(6A):43-50. PubMed ID: 6097124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
    LeFrock JL; Molavi A; McCloskey RV; Rolston K; Chandrasekar P; Henao L; Smith BR; Kannangara W; Schell RF; Carr BB
    Am J Med; 1984 Jul; 77(1):72-8. PubMed ID: 6331163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental and clinical studies of cefmenoxime in the field of obstetrics and gynecology].
    Takase Z; Noda K; Hayasaki M; Iwasa S; Motomura R; Yamabe T; Ichinohe K; Kutsuzawa T; Kaneko M; Domon H; Kodama M; Shimizu T; Mizoguchi H; Yorozu Y; Maki M; Chimura T; Matsuda S; Cho N; Fukunaga K; Kunii K; Wagatsuma T; Kaku R; Hogaki M; Ikawa M; Matsumoto Y; Fukuoka H; Honma T; Sanada K; Minakuchi H; Sumiyoshi Y; Hayashi S; Nakamura H; Goto T; Ihara Y; Hagiwara K; Tsuruta S; Yabuki A; Higashide K; Hasegawa Y; Ninomiya K; Okada H; Kanao M; Yasuda J; Takashima E; Ikeuchi M; Kobayashi Y; Haruta T; Hirabayashi K; Doko F; Watanabe K
    Jpn J Antibiot; 1982 Jun; 35(6):1585-609. PubMed ID: 6290708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of protein binding on cefmenoxime steady-state kinetics in critical patients.
    Reitberg DP; Cumbo TJ; Smith IL; Schentag JJ
    Clin Pharmacol Ther; 1984 Jan; 35(1):64-73. PubMed ID: 6317272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
    Bechard DL; Hawkins SH; Sutherland SC
    Am J Med; 1984 Dec; 77(6A):13-6. PubMed ID: 6097117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefmenoxime: clinical evaluation.
    Baker RL; Perkins RL
    Am J Med; 1984 Dec; 77(6A):53-9. PubMed ID: 6097126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum levels and sputum levels of cefmenoxime in respiratory tract infections].
    Matsumoto Y; Ninomaru S; Koshobu T; Ishikawa J; Nakatani S; Sasaki T
    Jpn J Antibiot; 1985 Jun; 38(6):1638-42. PubMed ID: 3862881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefmenoxime in surgical infections: treatment and penetration into peritoneal fluid and wound secretions.
    Wittke RR; Adam D
    Am J Med; 1984 Dec; 77(6A):7-10. PubMed ID: 6097127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic study of cefmenoxime concerning its transfer into tissues].
    Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
    Jpn J Antibiot; 1985 Jun; 38(6):1648-53. PubMed ID: 3862883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefmenoxime therapy in bacterial osteomyelitis.
    Sheftel TG; Cierny G; Lefrock JL; Mader JT
    Am J Med; 1984 Dec; 77(6A):17-20. PubMed ID: 6097118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of cefmenoxime in urinary tract and prostatic infections].
    Guibert J; Acar JF; Destree D; Bryskier A
    Pathol Biol (Paris); 1985 May; 33(5):330-4. PubMed ID: 3897962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on cefmenoxime (CMX) in urology].
    Tanaka H; Kato Y; Kakinoki K; Nishio S; Maekawa M; Tsujita M; Nishijima T; Kashihara N; Kono S; Hayahara N
    Hinyokika Kiyo; 1983 Jan; 29(1):95-103. PubMed ID: 6328956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transference of cefmenoxime from serum to lung tissue].
    Nagae N; Kobayashi M; Washio M
    Jpn J Antibiot; 1985 Jan; 38(1):41-4. PubMed ID: 3857361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of cefmenoxime in children.
    Tansino GF; Hammerschlag MR; Congeni BL; Cox PA; Doraiswamy B; duBouchet L
    Antimicrob Agents Chemother; 1985 Oct; 28(4):508-10. PubMed ID: 3865630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g].
    Veyssier P; Bryskier A; Modai J; Boquet A; Fourtillan JB
    Pathol Biol (Paris); 1986 Dec; 34(10):1081-3. PubMed ID: 3547264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basic and clinical studies on cefmenoxime in pediatric field].
    Aoyama R; Kakizaki Y; Ohnishi A; Izumi Y; Nagata K; Fujita M; Asuka N; Kudo M; Matsumura C; Chiba C; Takahashi Y; Tsushima N; Okamoto T; Kuronuma T; Haneda S
    Jpn J Antibiot; 1982 Oct; 35(10):2384-92. PubMed ID: 6306290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.